Cefixime and Anasarca - a phase IV clinical study of FDA data

Summary:

Anasarca is reported as a side effect among people who take Cefixime (cefixime), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Remicade, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Anasarca when taking Cefixime. It is created by eHealthMe based on reports of 3,217 people who have side effects when taking Cefixime from the FDA, and is updated regularly.

What is Cefixime?

Cefixime has active ingredients of cefixime. eHealthMe is studying from 3,237 Cefixime users. Check the latest studies of Cefixime.

What is Anasarca?

Anasarca (general swelling, or massive oedema) is found to be associated with 3,330 drugs and 2,900 conditions by eHealthMe. Check the latest studies of Anasarca.

On Apr, 22, 2026

3,217 people reported to have side effects when taking Cefixime.
Among them, 37 people (1.15%) have Anasarca.

Among these 37 people:

How long have people been on Cefixime when they have Anasarca? *

What is the gender of people who have Anasarca when taking Cefixime? *

female: 68.75 %
male: 31.25 %

What is the age of people who have Anasarca when taking Cefixime? *

What are other drugs people take besides Cefixime? *

What are other side effects people have besides Anasarca? *

Fatigue (feeling of tiredness): 17 people, 45.95%
Nausea (feeling of having an urge to vomit): 12 people, 32.43%
Headache (pain in head): 10 people, 27.03%
Diarrhea: 10 people, 27.03%
Neck Pain: 10 people, 27.03%
Oral Pustule: 9 people, 24.32%
Limb Discomfort (discomfort in leg): 9 people, 24.32%
Oral Candidiasis (fungal infection of mouth): 9 people, 24.32%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 9 people, 24.32%
Acne (skin problems that cause pimples): 9 people, 24.32%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 9 people, 24.32%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 6 people, 16.22%
Thyroid Diseases: 5 people, 13.51%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 13.51%
Functional Gastrointestinal Disorder (functional problem in separate organs of gastrointestinal system): 5 people, 13.51%
Ill-Defined Disorder: 2 people, 5.41%
Multiple Myeloma (cancer of the plasma cells): 2 people, 5.41%
Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 5.41%
Primary Immunodeficiency Syndrome: 2 people, 5.41%
Rashes (redness): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Cefixime and have Anasarca?

- Check whether Anasarca is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefixime:

Cefixime (3,237 reports)

Anasarca treatments and more:

Anasarca (115,736 reports)

Browse all side effects of Cefixime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Anasarca:

Anasarca (3,330 drugs)

Browse all the conditions that are associated with Anasarca:

Anasarca (2,900 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefixime (the active ingredients of Cefixime) and Cefixime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.